申请人:——
公开号:US20040242576A1
公开(公告)日:2004-12-02
The present invention relates to compounds of formula I
1
wherein
R
1
and R
2
are described herein, and their pharmaceutically acceptable salts thereof for the treatment of diseases, related to the A
2A
receptor.
本发明涉及式I1的化合物,其中R1和R2如本文所述,并且它们的药用可接受盐,用于治疗与A2A受体相关的疾病。